<DOC>
	<DOCNO>NCT02303808</DOCNO>
	<brief_summary>This trial aim analyze whether inhalation hypertonic saline combine positive expiratory pressure ( PEP ) device increase amount sputum expectorate chest physiotherapy session ( inhalation + bronchial drainage ) .</brief_summary>
	<brief_title>Positive Expiratory Pressure During Inhalation Hypertonic Saline Patients With Cystic Fibrosis</brief_title>
	<detailed_description>All patient perform two different arm treatment crossover randomization . Each arm treatment apply 5 consecutive day . The wash-out period one week . Before start trial patient inhalation formation . During study period patient ' pharmacological treatment remain unchanged</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Pass inhalation test Chronic sputum production , least â‰¥ 10 ml /24h Cystic Fibrosis ( CF ) diagnose ( establish genotype sweat sodium &gt; 70 mmol/l sweat chloride &gt; 60 mmol/l ) Clinically stable time recruitment ( defined requirement antibiotic change respiratory medication precede 4 week ) Trained use autogenic drainage technique ( least 6 month ) Inhaling hypertonic saline since least 6 month To able provide write , informed consent perform protocol evaluation Active massive hemoptysis previous 2 month Patient transplantation retransplantation list Patient already participate another study time</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Hyperosmolar agent</keyword>
	<keyword>Hypertonic saline</keyword>
	<keyword>Airway clearance technique</keyword>
	<keyword>Positive Expiratory Pressure</keyword>
	<keyword>Autogenic drainage</keyword>
</DOC>